This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
DICE Therapeutics 将来の成長
Future 基準チェック /06
We currently don't have sufficient analyst coverage to forecast growth and revenue for DICE Therapeutics.
主要情報
-22.3%
収益成長率
-14.8%
EPS成長率
| Pharmaceuticals 収益成長 | 27.3% |
| 収益成長 率 | 86.8% |
| 将来の株主資本利益率 | n/a |
| アナリストカバレッジ | Good |
| 最終更新日 | 09 Aug 2023 |
今後の成長に関する最新情報
Recent updates
We're Not Very Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Rate
May 14
DICE Therapeutics positive phase 1 data for psoriasis candidate leads shares 71% higher
Oct 11Here's Why We're Not Too Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Situation
Sep 11DICE Therapeutics GAAP EPS of -$0.58
Aug 11DICE Therapeutics initiated at buy at Wainwright on platform for small molecule drugs
Jul 18業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 12/31/2025 | 2 | -224 | -161 | -205 | 8 |
| 12/31/2024 | N/A | -169 | -161 | -155 | 9 |
| 12/31/2023 | N/A | -140 | -116 | -109 | 9 |
| 6/30/2023 | N/A | -104 | -87 | -84 | N/A |
| 3/31/2023 | N/A | -91 | -75 | -73 | N/A |
| 12/31/2022 | N/A | -84 | -67 | -64 | N/A |
| 9/30/2022 | N/A | -77 | -63 | -61 | N/A |
| 6/30/2022 | N/A | -74 | -56 | -54 | N/A |
| 3/31/2022 | 1 | -59 | -46 | -45 | N/A |
| 12/31/2021 | 1 | -49 | -40 | -39 | N/A |
| 9/30/2021 | 1 | -40 | -31 | -30 | N/A |
| 6/30/2021 | 2 | -29 | -27 | -27 | N/A |
| 3/31/2021 | 1 | -27 | -24 | -24 | N/A |
| 12/31/2020 | 1 | -24 | -21 | -21 | N/A |
| 12/31/2019 | 6 | -13 | -17 | -16 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: DICE is forecast to remain unprofitable over the next 3 years.
収益対市場: DICE is forecast to remain unprofitable over the next 3 years.
高成長収益: DICE is forecast to remain unprofitable over the next 3 years.
収益対市場: DICE is forecast to have no revenue next year.
高い収益成長: DICE is forecast to have no revenue next year.
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: Insufficient data to determine if DICE's Return on Equity is forecast to be high in 3 years time